CoChat

Colchicine versus Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Randomized Prospective Study

DOUGLAS, WILLIAM W., RYU, JAY H., SWENSEN, STEPHEN J., OFFORD, KENNETH P., SCHROEDER, DARRELL R., CARON, GAIL M., DeREMEE, RICHARD A. · 1998 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Twenty-six symptomatic subjects with clinical evidence plus either high-resolution computed tomography (HRCT, n = 25) or open-lung biopsy (OLB, n = 1) patterns typical for idiopathic usual interstitial pneumonia (idiopathic UIP) were entered into a randomized prospective treatment trial using high-dose prednisone (n = 12) versus colchicine (n = 14). The minimum dose of prednisone used was 60 mg/d for 1 mo, tapered to 40 mg/d over the second month, tapered to 40 mg every other day during the third month, with subsequent doses adjusted as clinically indicated. The dose of colchicine was 0.6–1.2 mg/d, as tolerated. The presence of a rim of subpleural honeycomb change was present in all of the 25 subjects who had HRCT. Subjects treated with high-dose prednisone alone experienced a higher incidence of serious side effects and also exhibited a trend (not statistically significant, p = 0.391) to more rapid decline of pulmonary function and shortened survival than did those treated with colchicine alone. In most subjects with typical clinical and HRCT features of idiopathic UIP, neither prednisone nor colchicine resulted in objective improvement, and the disease continued to progress in the majority. Colchicine appears to be a safer alternative to a trial of high-dose prednisone but may be no different than no therapy.

Overview

Integrity signals

Registry

Crossref · 10.1164/ajrccm.158.1.9709089

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 5

  1. Hampton, 1994, Corticosteroids in idiopathic pulmonary fibrosis (IPF): toxicity may outweigh benefits (abstract)., Am. Rev. Respir. Dis, 149, A878
  2. Miller, 1983, Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state., Am. Rev. Respir. Dis, 127, 270
  3. Miller, 1986, Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state., Bull. Eur. Physiopathol. Respir, 22, 589
  4. Midthun, 1998, Nonspecific interstitial pneumonia: clinical, radiographic, and pathologic features (abstract)., Am. J. Respir. Crit. Care Med, 157, A277
  5. Raghu, 1995, Interstitial lung disease: a diagnostic approach., Am. J. Respir. Crit. Care Med, 151, 909, 10.1164/ajrccm/151.3_pt_1.909 · doi:10.1164/ajrccm/151.3_pt_1.909

Cited by

See all 191

Metadata

Authors
DOUGLAS, W. W., RYU, J. H., SWENSEN, S. J., OFFORD, K. P., SCHROEDER, D. R., CARON, G. M., & DeREMEE, R. A.
Affiliations
Mayo Clinic (US)
Venue
American Journal of Respiratory and Critical Care Medicine
Published
1998-07-01
Volume
158
Issue
1
Pages
220-225
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1862182724
Cited by
182
References
25
Citations by year
2024: 4 · 2023: 1 · 2022: 6 · 2021: 5 · 2019: 1 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 8 · 2013: 9 · 2012: 4
FWCI
10.71
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
idiopathic pulmonary fibrosis, colchicine, prednisone, corticosteroid therapy, high-dose prednisone, adverse drug reactions, lung function decline, survival, disease progression
MeSH terms
Aged, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Colchicine, Female, Humans, Male, Middle Aged, Prednisone, Prospective Studies, Pulmonary Fibrosis, Respiratory Function Tests, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colchicine versus Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Randomized Prospective Study. https://app.cochat.ai/papers/10.1164/ajrccm.158.1.9709089
The paper
DOUGLAS, W. W., RYU, J. H., SWENSEN, S. J., OFFORD, K. P., SCHROEDER, D. R., CARON, G. M., & DeREMEE, R. A. (1998). Colchicine versus Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Randomized Prospective Study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.158.1.9709089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.